IDYA

IDEAYA Biosciences, Inc.

Healthcare · Biotechnology

$157.91 sample

-1.49 (-0.93%) 1D

Market cap

$290.6B

Price as of

2026-10-15

Latest filing

8-K · 2026-09-17

Alerts

8

Price$157.91 +9.45% 3M daily closessample

164.46142.79

2026-07-202026-08-112026-09-022026-09-232026-10-15

purchase / approvalsale / rejectionfiling / neutral

Latest events

Filings, trades, FDA; newest first

Oct 12INSInsider sell: Director
Oct 07INSInsider sell: General Counsel
Sep 30INSInsider sell: Director
Sep 22INSInsider sell: Director
Sep 17SECDEF 14A filed
Sep 10INSInsider buy: 10% owner
Sep 04INSInsider buy: Chief Executive Officer
Aug 26SECForm 144 filed

Sign up to see the real IDYA record →

Company facts

SEC EDGAR registration

Name: IDEAYA Biosciences, Inc.
Sector: Healthcare
Industry: Biotechnology
Smart-money score: +54sample, -100 to +100
Reporting currency: USD

Who is positioning in IDYA

sample

Insiders: 20 insider transactions over 90 days, net selling, $874.9M
Congress: 3 members traded over 90 days
Institutions · 13F: 33 funds hold $5.5B
Activists · 13D/G: No 13D/13G activist filings on record

How are the fundamentals trending?

sample, by period end

Revenue$9.8B +11.3% y/y

Q4 2024Q3 2026

Inventory$5.7B +10.0% y/y

Q4 2024Q3 2026

Accounts receivable$4.3B +6.5% y/y

Q4 2024Q3 2026

Total debt$12.2B +13.1% y/y

Q4 2024Q3 2026

Peers

sample

Sample peer A: $68.4B +2.7% 3M
Sample peer B: $232.4B +4.7% 3M
Sample peer C: $247.9B +13.3% 3M
Sample peer D: $235.7B -8.8% 3M
Sample peer E: $118.0B -5.6% 3M